KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Short-term Investments (2016 - 2025)

Sarepta Therapeutics has reported Short-term Investments over the past 14 years, most recently at $138.4 million for Q4 2025.

  • Quarterly results put Short-term Investments at $138.4 million for Q4 2025, down 45.04% from a year ago — trailing twelve months through Dec 2025 was $138.4 million (down 45.04% YoY), and the annual figure for FY2025 was $138.4 million, down 45.04%.
  • Short-term Investments for Q4 2025 was $138.4 million at Sarepta Therapeutics, down from $237.9 million in the prior quarter.
  • Over the last five years, Short-term Investments for SRPT hit a ceiling of $1.2 billion in Q4 2023 and a floor of $30.0 million in Q2 2021.
  • Median Short-term Investments over the past 5 years was $871.5 million (2022), compared with a mean of $662.5 million.
  • Biggest five-year swings in Short-term Investments: surged 3431.51% in 2022 and later tumbled 96.26% in 2024.
  • Sarepta Therapeutics' Short-term Investments stood at $30.0 million in 2021, then surged by 3308.66% to $1.0 billion in 2022, then grew by 22.02% to $1.2 billion in 2023, then crashed by 79.82% to $251.8 million in 2024, then tumbled by 45.04% to $138.4 million in 2025.
  • The last three reported values for Short-term Investments were $138.4 million (Q4 2025), $237.9 million (Q3 2025), and $289.5 million (Q2 2025) per Business Quant data.